FI941915A7 - 2-amino-4-heteroaryyli-1,4-dihydropyridiineja, menetelmiä niiden valmistamiseksi ja niiden käyttö lääkeaineissa - Google Patents

2-amino-4-heteroaryyli-1,4-dihydropyridiineja, menetelmiä niiden valmistamiseksi ja niiden käyttö lääkeaineissa Download PDF

Info

Publication number
FI941915A7
FI941915A7 FI941915A FI941915A FI941915A7 FI 941915 A7 FI941915 A7 FI 941915A7 FI 941915 A FI941915 A FI 941915A FI 941915 A FI941915 A FI 941915A FI 941915 A7 FI941915 A7 FI 941915A7
Authority
FI
Finland
Prior art keywords
dihydropyridines
pharmaceuticals
heteroaryl
amino
preparation
Prior art date
Application number
FI941915A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI941915A0 (fi
Inventor
Alexander Straub
Siegfried Goldmann
Juergen Stoltefuss
Martin Bechem
Rainer Gross
Siegbert Hebisch
Joachim Huetter
Howard-Paul Rounding
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI941915A0 publication Critical patent/FI941915A0/fi
Publication of FI941915A7 publication Critical patent/FI941915A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI941915A 1993-04-27 1994-04-25 2-amino-4-heteroaryyli-1,4-dihydropyridiineja, menetelmiä niiden valmistamiseksi ja niiden käyttö lääkeaineissa FI941915A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4313696A DE4313696A1 (de) 1993-04-27 1993-04-27 2-Amino-4-heteroaryl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln

Publications (2)

Publication Number Publication Date
FI941915A0 FI941915A0 (fi) 1994-04-25
FI941915A7 true FI941915A7 (fi) 1994-10-28

Family

ID=6486454

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941915A FI941915A7 (fi) 1993-04-27 1994-04-25 2-amino-4-heteroaryyli-1,4-dihydropyridiineja, menetelmiä niiden valmistamiseksi ja niiden käyttö lääkeaineissa

Country Status (17)

Country Link
US (2) US5434153A (enExample)
EP (1) EP0622365A1 (enExample)
JP (1) JPH06321943A (enExample)
CN (1) CN1100725A (enExample)
AU (1) AU671001B2 (enExample)
CA (1) CA2121963A1 (enExample)
CZ (1) CZ99594A3 (enExample)
DE (1) DE4313696A1 (enExample)
FI (1) FI941915A7 (enExample)
HU (1) HUT70540A (enExample)
IL (1) IL109439A0 (enExample)
NO (1) NO941519L (enExample)
NZ (1) NZ260385A (enExample)
PH (1) PH30808A (enExample)
RU (2) RU94014255A (enExample)
SK (1) SK47994A3 (enExample)
ZA (1) ZA942884B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004272078A1 (en) * 2003-09-10 2005-03-24 Synta Pharmaceuticals Corp. Dihydropyridine compounds for treating or preventing metabolic disorders
US8759341B2 (en) 2009-02-18 2014-06-24 Bayer Intellectual Property Gmbh Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946026A (en) * 1972-03-06 1976-03-23 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
US3989708A (en) * 1972-08-31 1976-11-02 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
DE2242786A1 (de) * 1972-08-31 1974-03-14 Bayer Ag Verfahren zur herstellung von neuen 2-amino-1,4-dihydropyridinen mit einer carbonylfunktion sowie ihre verwendung als arzneimittel
DE2639257A1 (de) * 1976-09-01 1978-03-02 Bayer Ag Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3311003A1 (de) * 1983-03-25 1984-09-27 Bayer Ag, 5090 Leverkusen Chromon- und thiochromonsubstituierte 1,4-dihydropyridinlactone, mehrere verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5254692A (en) * 1990-04-06 1993-10-19 Bayer Aktiengesellschaft 2,6-dialkyl-4-(benzothiazol- or benzoxazol-7-yl)-1,4-dihydropyridines
DE4011106A1 (de) * 1990-04-06 1991-10-10 Bayer Ag Neue heterocyclisch substituierte dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4117750A1 (de) * 1991-05-30 1992-12-24 Bayer Ag Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4134760A1 (de) * 1991-10-22 1993-07-08 Bayer Ag Aryl-chinolyl-substituierte 1,4-dihydropyridin-dicarbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4202526A1 (de) * 1992-01-30 1993-08-05 Bayer Ag Neue 4-cinnolinyl- und 4-naphthyridinyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
PH30808A (en) 1997-10-17
HUT70540A (en) 1995-10-30
HU9401191D0 (en) 1994-07-28
NZ260385A (en) 1996-04-26
RU94014627A (ru) 1997-02-20
US5434153A (en) 1995-07-18
CN1100725A (zh) 1995-03-29
AU5922294A (en) 1994-11-03
SK47994A3 (en) 1994-12-07
EP0622365A1 (de) 1994-11-02
CA2121963A1 (en) 1994-10-28
FI941915A0 (fi) 1994-04-25
AU671001B2 (en) 1996-08-08
US5478937A (en) 1995-12-26
RU94014255A (ru) 1997-02-20
DE4313696A1 (de) 1994-11-03
NO941519D0 (enExample) 1994-04-26
IL109439A0 (en) 1994-07-31
NO941519L (no) 1994-10-28
JPH06321943A (ja) 1994-11-22
CZ99594A3 (en) 1994-11-16
ZA942884B (en) 1995-01-04

Similar Documents

Publication Publication Date Title
FI934220A7 (fi) Piperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
EE9900147A (et) Oksadiasoolid, nende saamismeetodid ja kasutamine ravimitena
FI955140L (fi) Uusia kinoksaliinidionijohdannaisia, niiden valmistus ja käyttö lääkkeissä
FI944821L (fi) Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
FI944600A7 (fi) Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
FI944822L (fi) Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
FI944823L (fi) Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
EE9700288A (et) Asatsükloalkaani derivaadid, nende valmistamine ja kasutamine ravis
FI911615A7 (fi) Uusia 4-kinolyyli-dihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
FI931232L (fi) Makeutusaine, menetelmä sen valmistamiseksi ja sen käyttö
FI932145A7 (fi) Uudet b-karboliinijohdannaiset, niiden valmistus ja käyttö lääkeaineis sa
FI951631L (fi) Substituoituja kynureniinejä, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
FI941914A0 (fi) 2-amino-4-kinoliinidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö
FI953956A7 (fi) 2,3-rengaskondensoidut 1,4-dihydropyridiinit, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
FI972988L (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
FI941912L (fi) 3-kinolyylillä substituoidut dihydropyridiinit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
FI941911A7 (fi) Kondensoidut kinolyylidihydropyridiinit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
FI955679L (fi) Piperidiinijohdannaisia, niiden valmistus ja käyttö
FI922428A7 (fi) Uusia 2-amino-5-syaani-1,4-dihydropyridiinejä, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
FI885056A7 (fi) Uusia fluorimetoksifenyylidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö lääkkeissä
FI902901A7 (fi) Dibentsoli/1,5/dioksosiini-5-oni-johdannaisia, niiden käyttö lääkeaineissa ja menetelmä niiden valmistamiseksi
FI941963L (fi) Pyridiinijohdannaiset, niiden valmistus ja käyttö
FI921456A7 (fi) Substituoituja 2',3'-didesoksi-5-trifluorimetyyliuridiineja, menetelmiä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
FI924167A7 (fi) Indolisulfonamidilla substituoidut dihydropyridiinit, menetelmä niidenvalmistamiseksi ja niiden käyttö lääkeaineissa
FI941915A7 (fi) 2-amino-4-heteroaryyli-1,4-dihydropyridiineja, menetelmiä niiden valmistamiseksi ja niiden käyttö lääkeaineissa